Home > Insider Trading > Filing (0001415889-24-025826)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1802665	Harmony Biosciences Holdings Inc.	HRMY	Pharmaceutical Preparations (2834)	822279923

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1821102	Jeffrey Dierks	C/O Harmony Biosciences Holdings, Inc. 630 W Germantown Pike, Suite 215 Plymouth Meeting PA 19462	Chief Commercial Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-10-29	21,496	$24.00	21,496	No	4	M	Direct
Common Stock	Disposition	2024-10-29	21,496	$40.47	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2024-10-29	21,496	$0.00	21,496	$24.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
28,972		2030-08-18	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.94. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The stock option vests in five equal annual installments beginning on August 21, 2021.